Meet your hosts
Managing Director APAC,
Turnkey Consulting
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries
Global Practice Director,
Turnkey Consulting
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries
Business Development Specialist,
Turnkey Consulting
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries
Managing Director, Australia,
Turnkey Consulting
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries
Ed Davis
Managing Director APAC,
Turnkey Consulting
Simon Persin
Global Practice Director,
Turnkey Consulting
Shane Kennedy,
Business Development Specialist,
Turnkey Consulting
Robert Budic
Managing Director, Australia,
Turnkey Consulting
Because the pharmaceutical industry is so fast-paced, organisations face a difficult balancing act between agility and security when it comes to IAM, yet the conventional approach is leaving the data and research they have stored potentially vulnerable.
In this webinar, we were joined by Paul Squires, Lead Identity Strategist UK&I at SailPoint, to expand on how Identity Governance and Administration (IGA), an automated and centralised approach to IAM, can help pharmaceutical companies avoid the pitfalls of traditional methods and move towards more efficient and secure operations.
Specifically, we covered:
- Why both agility and security are critical in the pharmaceutical sector
- How digital innovation is widening the threat landscape
- The risks of ineffective identity management for pharma companies
- An introduction to IGA and the benefits it provides
Supported by:
